forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Monitoring Report: RA Prescribing Trends – September Data Monitoring Report: GLP-1 RA Prescribing

According to Rajiv Kovil, a medical expert in diabetes and weight-loss drugs, retatrutide could be the "biggest molecule" because of its action on the three receptors

If you have had gallstones before, even if they resolved, your risk of recurrence is substantially higher

As of the resolution of the shortage, compounding semaglutide that is an essential copy of Ozempic or Wegovy is generally no longer legal except in rare circumstances, such as when a patient has a documented allergy to a specific inactive ingredient in the brand-name product

Did you miss our previous Breaking News Dispatches from top Alzheimers and dementia conferences